{
  "Variants Include": [
    {
      "Gene": "a-Synuclein",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.E46K",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Protein Change": {
            "ref": "Glu",
            "alt": "Lys",
            "position": "46"
          },
          "Description in input context": "c.E46K"
        }
      ]
    },
    {
      "Gene": "a-Synuclein",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.A30P",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Pro",
            "position": "30"
          },
          "Description in input context": "c.A30P"
        }
      ]
    },
    {
      "Gene": "a-Synuclein",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.A53T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Protein Change": {
            "ref": "Ala",
            "alt": "Thr",
            "position": "53"
          },
          "Description in input context": "c.A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinsonâ€™s disease and dementia with Lewy bodies",
    "MONDO": "MONDO:0019547"
  },
  "Experiment Method": [
    {
      "Assay Method": "Phospholipid Binding Assay",
      "Material used": {
        "Material Source": "Protein expression system",
        "Material Name": "a-Synuclein variants (E46K, A30P, A53T)",
        "Description": "Recombinant a-synuclein proteins were expressed and purified."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.E46K",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased binding affinity",
          "Result Description": "E46K showed increased phospholipid binding compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.A30P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding affinity",
          "Result Description": "A30P showed reduced phospholipid binding compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.A53T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Intermediate binding affinity",
          "Result Description": "A53T showed intermediate phospholipid binding compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "No explicit mention of biological replicates in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "No explicit mention of technical replicates in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of positive controls in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of negative controls in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "No explicit mention of statistical methods in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Phospholipid binding assays are commonly used in neurodegenerative research."
      }
    },
    {
      "Assay Method": "Filament Assembly Assay",
      "Material used": {
        "Material Source": "In vitro protein system",
        "Material Name": "a-Synuclein variants (E46K, A30P, A53T)",
        "Description": "Recombinant a-synuclein proteins were subjected to in vitro filament formation assays."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.E46K",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Promotes filament formation",
          "Result Description": "E46K showed increased propensity for filament formation compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.A30P",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduces filament formation",
          "Result Description": "A30P showed reduced propensity for filament formation compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.A53T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Intermediate filament formation",
          "Result Description": "A53T showed intermediate propensity for filament formation compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "No explicit mention of biological replicates in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "No explicit mention of technical replicates in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "No explicit mention of positive controls in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "No explicit mention of negative controls in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "No explicit mention of statistical methods in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Description": "Filament assembly assays are standard in studying amyloidogenic proteins."
      }
    }
  ]
}